Immunovant (NASDAQ:IMVT) reported quarterly losses of $(0.41) per share. This is a 17.14 percent decrease over losses of $(0.35) per share from the same period last year.
Neenah Earnings Perspective: Return On Capital Employed
According to Benzinga Pro, during Q1, Neenah (NYSE:NP) earned $5.70 million, a 183.82% increase from the preceding quarter. Neenah also posted a total of $284.80 million in sales, a 7.76% increase since Q4.
